189 related articles for article (PubMed ID: 23997240)
1. Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.
Ottaviani S; Brooke GN; O'Hanlon-Brown C; Waxman J; Ali S; Buluwela L
J Mol Endocrinol; 2013 Dec; 51(3):301-12. PubMed ID: 23997240
[TBL] [Abstract][Full Text] [Related]
2. Androgen response element of the glycine N-methyltransferase gene is located in the coding region of its first exon.
Lee CM; Yen CH; Tzeng TY; Huang YZ; Chou KH; Chang TJ; Arthur Chen YM
Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23883094
[TBL] [Abstract][Full Text] [Related]
3. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
[TBL] [Abstract][Full Text] [Related]
4. The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer.
Song YH; Shiota M; Kuroiwa K; Naito S; Oda Y
Mod Pathol; 2011 Sep; 24(9):1272-80. PubMed ID: 21572396
[TBL] [Abstract][Full Text] [Related]
5. TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.
Asuthkar S; Velpula KK; Elustondo PA; Demirkhanyan L; Zakharian E
Oncotarget; 2015 Jul; 6(19):17221-36. PubMed ID: 25980497
[TBL] [Abstract][Full Text] [Related]
6. Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.
D'Antonio JM; Vander Griend DJ; Antony L; Ndikuyeze G; Dalrymple SL; Koochekpour S; Isaacs JT
PLoS One; 2010 Jul; 5(7):e11475. PubMed ID: 20628607
[TBL] [Abstract][Full Text] [Related]
7. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
Bohrer LR; Chen S; Hallstrom TC; Huang H
Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
[TBL] [Abstract][Full Text] [Related]
8. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.
Whitworth H; Bhadel S; Ivey M; Conaway M; Spencer A; Hernan R; Holemon H; Gioeli D
PLoS One; 2012; 7(6):e38950. PubMed ID: 22761715
[TBL] [Abstract][Full Text] [Related]
9. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
Cherian MT; Wilson EM; Shapiro DJ
J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
[TBL] [Abstract][Full Text] [Related]
10. Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells.
Zhang L; Zhao Z; Xu S; Tandon M; LaValle CR; Deng F; Wang QJ
Oncotarget; 2017 Feb; 8(8):12800-12811. PubMed ID: 28077787
[TBL] [Abstract][Full Text] [Related]
11. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
12. ING3 promotes prostate cancer growth by activating the androgen receptor.
Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
[TBL] [Abstract][Full Text] [Related]
13. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
[TBL] [Abstract][Full Text] [Related]
15. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
Daniels G; Li Y; Gellert LL; Zhou A; Melamed J; Wu X; Zhang X; Zhang D; Meruelo D; Logan SK; Basch R; Lee P
Endocr Relat Cancer; 2014 Feb; 21(1):127-42. PubMed ID: 24243687
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of androgen receptor targets reveals COUP-TF1 as a novel player in human prostate cancer.
Perets R; Kaplan T; Stein I; Hidas G; Tayeb S; Avraham E; Ben-Neriah Y; Simon I; Pikarsky E
PLoS One; 2012; 7(10):e46467. PubMed ID: 23056316
[TBL] [Abstract][Full Text] [Related]
17. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
18. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
19. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells.
Kim JY; Yu J; Abdulkadir SA; Chakravarti D
Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279
[TBL] [Abstract][Full Text] [Related]
20. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.
Frigo DE; Sherk AB; Wittmann BM; Norris JD; Wang Q; Joseph JD; Toner AP; Brown M; McDonnell DP
Mol Endocrinol; 2009 Sep; 23(9):1385-96. PubMed ID: 19460858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
